Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001352413-13-000005
Filing Date
2013-09-19
Accepted
2013-09-19 17:12:46
Documents
1
Period of Report
2013-09-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5849
  Complete submission text file 0001352413-13-000005.txt   7141
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Capone Mark Christopher (Reporting) CIK: 0001352413 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 131106113